Third Annual International IP Summit

2021 Agenda and Program

---

International IP Summit Brochure

Please join Boston College Law School and Ropes & Gray at our 3^rd Annual International IP Summit. The summit is a premier forum for practitioners, business leaders, academics, and government officials to explore the dramatically evolving global IP environment.

CLE provided for CA, IL and NY

Featuring keynote by Sandra Leung

Sandra Leung Executive Vice President, General Counsel Bristol Myers Squibb

Date	Time All times are EST	Panel
October 20	12:00-12:20PM	Welcome Remarks
	12:20-1:00PM	Keynote Address
	1:10-2:30PM	Legal Issues in the Development, Production and Distribution of Vaccines and Treatments for COVID-19
	5:00-6:30PM	NETWORKING: Live Virtual Mixology Class and Interactive Cocktail Hour
October 21	9:00-10:30AM	Digital Health in China
	12:00-12:50PM	Hot Topics and Emerging Trends in IP and Innovation
	1:00-2:00PM	Dealmaking in Times of Escalating International Sanctions and Trade Disputes
October 22	10:00-11:00AM	Leading and Thriving in a Time of Disruption and Uncertainty: A Conversation with General Counsels
	12:00-12:50PM	Life Sciences Regulatory Update: US, Europe and China
	1:00-2:00PM	Cross-Border IP Protection and Enforcement in a Changing Landscape
October 23 By invitation or application only	12:30-1:00PM	Opening & Introductory Presentation
	1:00-3:30PM	Interactive Workshop: Doing Business in Uncertain Times

---

• Welcome Remarks 
  12:00-12:10PM
• Dean Vincent Rougeau, Boston College Law School
• Remarks by Co-Chairs
  12:10-12:20PM
• Keynote Address
  12:20-1:00PM
• Sandra Leung, Executive Vice President, General Counsel, Bristol Myers Squibb
  Moderated by Charlotte Jacobsen, Partner, Ropes & Gray LLP
• Break
  1:00-1:10PM
• Legal Issues in the Development, Production and Distribution of Vaccines and Treatments for COVID-19
  1:10-2:30PM
  Companies, universities, and governments are racing to produce vaccines and other treatments to address the ongoing COVID-19 pandemic. The production and distribution of these vaccines and treatments are impacted not just by regulatory frameworks imposed by the FDA, and similar organizations, but also by intellectual property rights and laws. This session will explore these issues, including:
• How do we incentivize production of vaccines and therapeutics? 
• How do we address compulsory licensing, without killing the incentive to produce?
• Considerations for and challenges posed by rolling out biological, regulated products on a massive scale in a short period of time
• Overview of regulatory changes and considerations in the US and from around the world to address the pandemic
• Speakers:
• Julie Barnes-Weise, Executive Director, Global Healthcare Innovation Alliance Accelerator
• David Halstead, Partner, Foley Hoag LLP
• Shaun Ryan, Senior Vice President & Deputy General Counsel, Moderna, Inc.
• Joanna Wu, General Counsel, HiFiBiO Inc.
• David Olson, Professor, Boston College Law School (Moderator)
• NETWORKING: Live Virtual Mixology Class and Interactive Cocktail Hour
  5:00-6:30PM

---

• Digital Health in China
  9:00-10:30AM
  The Chinese government has been promoting the development of digital health to counter the uneven distribution of healthcare delivery across the country. Many pharmaceutical and medtech companies have been taking advantage of AI and big data to develop new products and services that suit this new paradigm. Nevertheless, the collection, use, and outbound transmission of health data by foreign companies is subject to government approval and even security review. Foreign companies must collaborate with Chinese entities in order to legitimately collect health data and intellectual property derived from the collaboration could be subject to joint ownership. In this session we will discuss the IP, data, and regulatory issues companies may encounter in their digital health initiatives.
• What are the emerging technology trends in the life sciences sector?
• What regulatory requirements should companies be aware of when they launch digital health initiatives in China?
• Considerations for life science companies when leveraging the power of and protecting digital health technologies?
• Speakers:
• David Chen, Counsel, Ropes & Gray LLP
• Serina Tang, Associate Partner, McKinsey & Company 
• Katherine Wang, Partner, Ropes & Gray LLP
• Sally Wang Liang, Vice President of Business Development, PepLib; General Counsel, The US-China Health Summit (Moderator)
• Hot Topics and Emerging Trends in IP and Innovation
  12:00-12:50PM
  This panel will focus on recent intellectual property trends, including cases, legislation, and emerging trends, that will shape IP’s role in innovation in the coming years.  The topics will include patents, trademark, copyright, and data use rights domestically and internationally, including developments in the licensing of standard essential patents (SEPs) critical to 5G, the role of the ITC in brand protection and anti-counterfeiting in cross-border cases, emerging trends on data scraping and data use, etc.
• Speakers:
• Steven Geiszler, U.S. Chief Intellectual Property Litigation Counsel, Huawei
• Maria Hipps, Assistant General Counsel, Regional Legal Lead, LatAm, IQVIA
• Melissa Rones, Partner, Ropes & Gray LLP 
• Joseph Liu, Professor of Law, Boston College Law School (Moderator)
• Break
  12:50-1:00PM
• Dealmaking in Times of Escalating International Sanctions and Trade Disputes
  1:00-2:00PM
  In recent years, the U.S. government has embarked on a coordinated effort to ratchet up pressure on China, with significant implications on trade between China and the United States. The panel will explore risks posed by these changes, as well as strategies for dealing with those risks. Topics to be covered include:
• Political and economic implications of the U.S.-China trade war
• Implementation of the U.S.-China trade agreement and practical implications for companies conducting business in China
• CFIUS and the impact of FIRRMA on fundraising and technology transactions
• Speakers:
• Yasheng Huang, Epoch Foundation Professor of International Management, MIT Sloan School of Management
• Michael Mangelson, Principal Counsel and Director for China IP, U.S. Patent and Trademark Office
• Richard Sofield, Partner, Wiley Rein LLP, Former Director of the Foreign Investment Review Section, United States Department of Justice
• Brendan Hanifin, Counsel, Ropes & Gray LLP (Moderator) 

---

• Leading and Thriving in a Time of Disruption and Uncertainty: A Conversation with General Counsels
  10:00-11:00AM
  Companies, particularly those in the tech and life sciences sectors, are facing an unprecedented challenge as they navigate a pandemic that has disrupted everything from supply chains to life as we know it. Many companies have been forced to make dramatic changes to their business models and to adapt to a new normal. The GCs on our panel lead legal organizations in some of the fastest-growing companies in America. In this session, they will share the challenges they face, and strategies for leading and thriving in these uncertain times.
• Speakers:
• Heidy Abreu King-Jones, Chief Legal Officer & Corporate Secretary, Provention Bio Inc.
• Esther Dominguez, General Counsel, .406 Ventures 
• Brian Elworthy, General Counsel, Toast, Inc.
• Scott Samuels, Senior Vice President, General Counsel, BeiGene, Ltd.
• Duane Valz, Vice President & General Counsel, Insitro
• Regina Sam Penti, Partner, Ropes & Gray LLP (Moderator)
• Life Sciences Regulatory Update: US, Europe and China
  12:00-12:50PM
  The Life Sciences industry has been one of the most dynamic and active areas in international trade relations. For U.S. companies looking for local collaboration partners or seeking market access in China and Europe (and vice versa for Chinese and European companies) navigating the complicated and ever-changing regulatory landscape presents a major challenge. This panel will explore the distinctive aspects of the regulatory regime for the life sciences industry and recent updates. Topics will include:
• FDA policies during the COVID-19 pandemic
• Regulation of digital health and data 
• IP landscape and regulatory exclusivity
• Considerations regarding government investigations and compliance 
• Impact of regulatory regime and any roadblocks on partnerships and collaborations
• Speakers:
• Kathryn Harris, Senior Director & Compliance Counsel (Investigations), Alexion Pharmaceuticals, Inc.
• Shaun Ryan, Senior Vice President & Deputy General Counsel, Moderna, Inc.
• Sally Wang Liang, Vice President of Business Development, PepLib; General Counsel, The US-China Health Summit
• Yang Xu, Assistant General Counsel, Intellectual Property, BeiGene, Ltd.
• Kellie Combs, Partner, Ropes & Gray LLP (Moderator)
• Break
  12:50-1:00PM
• Cross-Border IP Protection and Enforcement in a Changing Landscape
  1:00-2:00PM
  This panel will examine recent developments in multi-jurisdictional IP protection and enforcement, particularly in the United States, China, and Europe, including:
• Safeguarding and enforcing IP (including trade secrets, branding, and patented inventions) in China;
• Global FRAND licensing requirements for Standard Essential Patents after Sisvel and Unwired Planet;
• Enforcement of life sciences IP and government-authorized infringement of pharmaceutical patents in the era of COVID.
• Speakers:
• Sam Brenner, Counsel, Ropes & Gray LLP
• Brendan Gavin, Intellectual Property Senior Counsel, Vertex Pharmaceuticals, Inc.
• Mathias Karlhuber, Patent Attorney, Equity Partner, Cohausz & Florack
• Michael Mangelson, Principal Counsel and Director for China IP, U.S. Patent and Trademark Office
• Charlotte Jacobsen, Partner, Ropes & Gray LLP (Moderator)

---

By invitation or application only

• Opening & Introductory Presentation
  12:30-1:00PM
•  Beibei Sun, Associate, Ropes & Gray LLP
• Interactive Workshop: Doing Business in Uncertain Times
  1:00-3:30PM
  The October 23 Roundtable session is by application and invitation only. This session will gather together people with significant expertise and experience in international IP law and business to share what they are seeing in the market and brainstorm best practices in these uncertain times. The roundtable will be a fully-interactive three-hour session. Participants are expected to attend the entire roundtable. The topics to be discussed at this roundtable include:
• Deal Making during a Pandemic: Experiences and Strategies
  • Minh-Chau Le, Partner, Ropes & Gray LLP (Moderator)
  • Amanda McGrady Morrison, Partner, Ropes & Gray LLP (Moderator)
• Global Collaboration and the Role of Policy to Ensure Public Access to Diagnostics, Medicines and Care
  • Julie Barnes-Weise, Executive Director, Global Healthcare Innovation Alliance Accelerator (Moderator)
  • Gillian Fenton, Senior Counsel, Vaccines Legal Operations, GSK (Moderator)
• Rebuilding the New World Order Post-COVID and the Role of IP
  • Melissa Rones, Partner, Ropes & Gray LLP (Moderator)
  • Peter K. Yu, Professor of Law and Communication, Texas A&M University (Moderator)